TheEdgeResearch
Home / Stocks / NSRS

North Springs Resources Corp (NSRS)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$35,902
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.97
52-Wk Range
0.0001-0.0001
CEO
John E. Vivian
Country
US
Currency
USD

North Springs Resources Corp operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Riverview, FL, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $35,902. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of 0.0%. Its beta of 1.97 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.00
Price / Book
-0.00
EV / EBITDA
0.00
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
-0.12
Current ratio
0.01
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
1
IPO date
2011-07-06
Headquarters
Riverview, FL, US
About North Springs Resources Corp

North Springs Resources Corp. is primarily engaged in the assessment, procurement, exploration, and advancement of properties containing mineral resources. Additionally, the company diversifies its activities to include the acquisition and innovation of various products and services within the pharmaceutical and medical technology sectors. Founded in 2009, the firm underwent a name change from Aurum Resources Corp. to North Springs Resources Corp. in June 2011. Its operational headquarters are located in Riverview, Florida.

Comparable companies

North Springs Resources Corp is most often compared with the following Healthcare names:

AXRXCHHLDECNNUNZPRCNFPSIQQEBRTNPHWMGRWSRC
More research on NSRS
NSRS technical analysis NSRS TheEdge Score Compare against peers
Open full interactive analysis & DCF →